Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inpatient Payment Proposal In Brief

This article was originally published in The Gray Sheet

Executive Summary

ICD payments refined: CMS proposes to distinguish between procedures for implantable cardioverter defibrillator leads and ICD pulse generators in fiscal year 2009 with new Medicare severity diagnosis-related groups (MS-DRGs). Although the average length of hospital stay related to both types of procedures is similar, charges for cases of implantation or replacement of defibrillator leads average $42,896, while those for implantation or replacement of pulse generators average $72,866, according to a CMS analysis in its proposed hospital inpatient 1payment rule, released April 14. The proposed split in payment classifications was manufacturer-requested, CMS notes

You may also be interested in...



OIG Allows Two More Gainsharing Programs; CMS Demos Still Pending

Two more hospital/physician gainsharing programs focused on product standardization got the HHS Office of Inspector General's OK Jan. 14

AdvaMed Calls For Guidance On Physician Investment In Device Firms

AdvaMed is soliciting guidance from the HHS Office of Inspector General (OIG) regarding potentially unlawful arrangements between device manufacturers and physicians

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel